Skip to main content
Log in

Evaluation of antitumor activity of rubomycin deposited in absorbable polymeric microparticles

  • Oncology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

An experimental dosage form of rubomycin is developed: the drug is incorporated in absorbable polymeric (polyhydroxybutyrate) matrix in the form of microparticles. Antitumor efficiency of this rubomycin dosage form was studied in laboratory mice with transplanted Ehrlich ascitic carcinoma. Rubomycin deposited in polymeric microparticles exhibited pronounced antitumor activity, inhibited the proliferative activity of Ehrlich ascitic carcinoma, and improved survival of mice with tumors. This dosage form of the drug can be used for local injections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. F. I. Ataullakhanov, T. V. Batasheva, and V. M. Vitvitskii, Antibiot. Khimioter., 39, No. 9–10, 26–29 (1993).

    Google Scholar 

  2. T. G. Volova, V. I. Sevast’yanov, and E. I. Shishatskaya, Polyhydroxylalcanoates: Biodegraded Polymers for Medicine [in Russian], Ed. V. I. Shumakov, Krasnoyarsk (2006).

  3. A. M. Genin, A. E. Il’in, A. S. Kaplanskii, et al., Aviakosm. Ekol. Med., 35, No. 4, 14–20 (2001).

    CAS  Google Scholar 

  4. BIOPLASTOTAN Trademark, Registration Certificate No. 315652, Federal Institute of Patent Expert Evaluations, application No. 2006703271/50, priority of 15.02.06. MKTU Classes: 01, 05, 10.

  5. E. I. Shishatskaya, A. V. Zhemchugova, and T. G. Volova, Antibiot. Khimioter., Nos. 2–3, 3–14 (2005).

  6. E. I. Shishatskaya and A. Goreva, Perspektivnye Materialy, No. 4, 65–70 (2006).

  7. D. Y. Furgeson, M. R. Dreher, and A. Chilkoti, J. Control Release, 110, No. 2, 362–369 (2006).

    Article  PubMed  CAS  Google Scholar 

  8. D. A. Gewirtz, Biochem. Pharmacol., 57, No. 7, 727–741 (1999).

    Article  PubMed  CAS  Google Scholar 

  9. G. A. Husseini, N. Y. Rapoport, D. A. Christensen, et al., Colloid Surf. B: Bionterf., 24, No. 3, 253–264 (2002).

    Article  CAS  Google Scholar 

  10. J. Kost and R. Langer, Adv. Drug Deliv. Rev., 46, Nos. 1–3, 125–148 (2001).

    Article  PubMed  CAS  Google Scholar 

  11. E. S. Lee, K. Na, and Y. H. Bae, J. Control Release, 103, No. 2, 405–418 (2005).

    Article  PubMed  CAS  Google Scholar 

  12. R. Lin, L. Shing, and C. H. Wang, Biomaterials, 26, No. 21, 4476–4485 (2005).

    Article  PubMed  CAS  Google Scholar 

  13. S. Q. Liu, Y. W. Tong, and Yi. Y. Yang, Ibid., 26, No. 24, 5064–5074 (2005).

    Article  PubMed  CAS  Google Scholar 

  14. J. L. West, Nat. Mater., 2, No. 11, 709–710 (2003).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. G. Volova.

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 145, No. 3, pp. 333–336, March, 2008

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shishatskaya, E.I., Goreva, A.V., Voinova, O.N. et al. Evaluation of antitumor activity of rubomycin deposited in absorbable polymeric microparticles. Bull Exp Biol Med 145, 358–361 (2008). https://doi.org/10.1007/s10517-008-0091-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-008-0091-9

Key Words

Navigation